N,N-DIMETHYL-3-[[5-(3-METHYL-2-OXO-1-TETRAHYDROPYRAN-4-YL-IMIDAZO[4,5-C]QUINOLIN-8-YL)-2-PYRIDYL]OXY]PROPAN-1-AMINE OXIDE USED AS A MODULATOR OF ATM (ATAXIA TELANGIECTASIA MUTATED) PROTEIN KINASE TO TREAT CANCER
MA44603AUndetermined Publication Date: 2019-02-13ASTRAZENECA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA44603
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2016-04-07
- Filing Date
- 2017-03-30
- Publication Date
- 2019-02-13
Need to check novelty before this filing date? Find Prior Art
No text content released.